627-77-0 | Dl-citrulline

Packsize	Purity	Availability	Price	Discounted Price
50mg	97%	in stock	$15.00	$10.00
1g	97%	in stock	$25.00	$17.00
5g	97%	in stock	$58.00	$40.00
10g	97%	in stock	$108.00	$76.00
25g	97%	in stock	$238.00	$166.00
100g	97%	in stock	$756.00	$529.00

Description

• Catalog Number: AB61145
• Chemical Name: Dl-citrulline
• CAS Number: 627-77-0
• Molecular Formula: C6H13N3O3
• Molecular Weight: 175.1857
• MDL Number: MFCD00007955
• SMILES: NC(=O)NCCCC(C(=O)O)N

Computed Properties

• Complexity: 171
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1
• XLogP3: -4.3

Literature

• Genetics of rheumatoid arthritis: what have we learned?

  Immunogenetics 20110801

• Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea.

  Intensive care medicine 20110201

• [Anticitrullin antibodies--modern markers of rheumatoid arthritis].

  Terapevticheskii arkhiv 20110101

• Developments in the scientific understanding of rheumatoid arthritis.

  Arthritis research & therapy 20090101

• [The diagnostic accuracy of anti-citrullin antibody assessment in the diagnosis of patients suspected of rheumatoid arthritis by a general practitioner].

  Nederlands tijdschrift voor geneeskunde 20080112

• Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia.

  European journal of clinical investigation 20080101

• Redox mechanisms in hepatic chronic wound healing and fibrogenesis.

  Fibrogenesis & tissue repair 20080101

• METANNOGEN: compiling features of biochemical reactions needed for the reconstruction of metabolic networks.

  BMC systems biology 20070101

• Nitric oxide and cardiovascular risk factors.

  Heart international 20070101

• Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.

  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20051001

• Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.

  European journal of clinical investigation 20050101

• [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].

  Terapevticheskii arkhiv 20050101

• [Severe fulminant form of neonatal citrullinemia. Report of a case].

  Revista de neurologia 20030401

• Auto-protective redox buffering systems in stimulated macrophages.

  BMC immunology 20020101

• Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

  BMC infectious diseases 20020101

• Reactivity of two anti-galactosyl ceramide antibodies towards myelin basic protein.

  Journal of the neurological sciences 19920301